Top

Published in:

01-04-2010 | Case Report

Pseudoachalasia Secondary to Metastatic Breast Carcinoma

Authors: J. M. Paulsen, G. C. Aragon, M. A. Ali, F. J. Brody, M. L. Borum

Published in: Digestive Diseases and Sciences | Issue 4/2010

Excerpt

Pseudoachalasia is a rare disorder of esophageal motility that has clinical and diagnostic features consistent with achalasia [1, 2]. The most common etiology of pseudoachalasia is malignancy and the most common pathology is primary esophageal adenocarcinoma [3‐6]. Metastatic disease rarely is implicated in cases of pseudoachalasia and few of these cases involve breast carcinoma [7‐11]. This is only the third reported case of pseudoachalasia resulting from metastatic infiltrating ductal carcinoma of the gastroesophageal junction. …

Horvath W. Dilation of the esophagus without anatomical stenosis. Proc R Soc Med. 1919;12:64.

Tracey JP, Traube M. Difficulties in the diagnosis of pseudoachalasia. Am J Gastroenterol. 1994;89(11):2014–2018.PubMed

Gockel I, Eckardt VF, Schmitt T, Junginger T. Pseudoachalasia: A case series and analysis of the literature. Scand J Gastroenterol. 2005;40:378–385. doi:10.1080/00365520510012118.CrossRefPubMed

Kahrilas PJ, Kishk SM, Helm JF, Dodds WJ, Harig JM, Hogan WJ. Comparison of pseudoachalasia and achalasia. Am J Med. 1987;82:439–446. doi:10.1016/0002-9343(87)90443-8.CrossRefPubMed

Liu W, Fackler W, Rice TW, Richter JE, Achkar E, Goldblum JR. The pathogenesis of pseudoachalasia: A clinicopathologic study of 13 cases of a rare entity. Am J Surg Pathol. 2002;26(6):784–788. doi:10.1097/00000478-200206000-00013.CrossRefPubMed

Seo P. Cases from the Osler Medical Service at Johns Hopkins University: Diagnosis: Pseudoachalasia due to esophageal adenocarcinoma. Am J Med. 2002;113:522–524. doi:10.1016/S0002-9343(02)01317-7.CrossRefPubMed

Abrams HL, Spiro R, Goldstein N. Metastases in carcinoma: Analysis of 1,000 autopsied cases. Cancer. 1950;3(1):74–85. doi:10.1002/1097-0142(1950)3:1<74::AID-CNCR2820030111>3.0.CO;2-7.CrossRefPubMed

Herrera JL. Case report: Esophageal metastasis from breast carcinoma presenting as achalasia. Am J Med Sci. 1992;303(5):321–323. doi:10.1097/00000441-199205000-00011.CrossRefPubMed

Moonka R, Patti MG, Feo CV, et al. Clinical presentation and evaluation of malignant pseudoachalasia. J Gastrointest Surg. 1999;3(5):456–461. doi:10.1016/S1091-255X(99)80097-3.CrossRefPubMed

10.

Graham WP, Goldman L. Gastro-intestinal metastases from carcinoma of the breast. Ann Surg. 1964;159(3):362–367. doi:10.1097/00000658-196403000-00004.CrossRefPubMed

11.

Goldberg RI, Rams H, Stone B, Barkin JS. Dysphagia as the presenting symptom of recurrent breast carcinoma. Cancer. 1987;60:1085–1088. doi:10.1002/1097-0142(19870901)60:5<1085::AID-CNCR2820600527>3.0.CO;2-8.CrossRefPubMed

12.

Nazareno J, Taves D, Preiksaitis HG. Metastatic breast cancer to the gastrointestinal tract: a case series and review of the literature. World J Gastroenterol. 2006;12(38):6219–6224.PubMed

13.

Portale G, Costantini M, Zaninotto G, et al. Pseudoachalasia: Not only esophago-gastric cancer. Dis Esophagus. 2007;20:168–172. doi:10.1111/j.1442-2050.2007.00664.x.CrossRefPubMed

14.

Rozman RW, Achkar E. Features distinguishing secondary achalasia from primary achalasia. Am J Gastroenterol. 1990;85(10):1327–1330.PubMed

15.

Borst MJ, Ingold JA. Metastatic patterns of invasive lobular versus invasive ductal carcinoma of the breast. Surgery. 1993;114(4):637–642.PubMed

16.

Tucker HJ, Snape WJ, Cohen S. Achalasia secondary to carcinoma: Manometric and clinical features. Ann Intern Med. 1978;89:315–318.PubMed

17.

Sandler RS, Bozymski EM, Orlando RC. Failure of clinical criteria to distinguish between primary achalasia and achalasia secondary to tumor. Dig Dis Sci. 1982;27(3):209–213. doi:10.1007/BF01296916.CrossRefPubMed

Title: Pseudoachalasia Secondary to Metastatic Breast Carcinoma
Authors: J. M. Paulsen
G. C. Aragon
M. A. Ali
F. J. Brody
M. L. Borum
Publication date: 01-04-2010
Publisher: Springer US
Published in: Digestive Diseases and Sciences / Issue 4/2010
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI: https://doi.org/10.1007/s10620-009-0809-1

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 4/2010

Characterization of High-Fat, Diet-Induced, Non-alcoholic Steatohepatitis with Fibrosis in Rats

Eosinophilic Esophagitis: Perspectives of Adult and Pediatric Gastroenterologists

Aquaporin-2 Urinary Excretion in Cirrhosis: Relationship to Vasopressin and Nitric Oxide

Determinants of Accelerated Small Intestinal Transit in Alcohol-Related Chronic Pancreatitis

Melatonin Modulates the Severity of Taurocholate-Induced Acute Pancreatitis in the Rat

Upregulation and CpG Island Hypomethylation of the TRF2 Gene in Human Gastric Cancer

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials